Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This study evaluates the feasibility of a treatment paradigm that involves naturalistic cocaine use opportunities in the context of psychotherapy aimed at utilizing these opportunities therapeutically.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cocaine Use Disorders

Clinical Trial Details

NCT number	NCT02373124
Study type	Interventional
Source	New York State Psychiatric Institute
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	December 2014
Completion date	October 2016

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01639157` - Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine	N/A
	Completed	`NCT00759473` - D-Cycloserine Facilitation of Cocaine - Cue Extinction	Phase 2
	Completed	`NCT00780442` - D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals	Phase 2
	Completed	`NCT00178776` - A Transtheoretical Model Group Therapy for Cocaine	Phase 1
	Recruiting	`NCT02680288` - Lorcaserin Intra Venous Cocaine Effects	Phase 1/Phase 2
	Completed	`NCT02909101` - Project IMPACT: Improving Memory Performance by Applying Cognitive Training	N/A
	Completed	`NCT01739192` - A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence	Early Phase 1
	Completed	`NCT01495195` - Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior	Phase 2